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Marion Reid and Christine Lomas-Francis published
the second edition of The Blood Group Antigen
FactsBook in 2004. Transfusion medicine specialists
thought it was THE reference book for facts and
information about blood group antigens. Although this
is still true today, it is somewhat difficult carrying a 561-
page book on rounds or between laboratories. Reid and
Lomas-Francis recently published the pocketbook sized
Blood Group Antigens & Antibodies: A Guide to
Clinical Relevance & Technical Tips with helpful
variations in formats.
Individual antigens are listed in alphabetical order,
but are also color-coded (blue, green, and red
representing polymorphic and low- and high-prevalence
antigens). Information is easier to locate as antigens are
arranged in color-coded tabs at the edge of each page. A
consistent format is used to provide the following
information on each antigen: clinical significance,
number of antigen-negative donors per 100, in vitro
characteristics of the alloantibody, technical tips, and
comments. Several informative tables, such as low-
prevalence antigens present in ethnic populations and
the effects of enzymes and chemicals on antigens, are
provided.
I do miss the molecular diagrams and references
from the earlier edition. However, including them
would add pages, and the pocket-size book would no
longer be easy to carry. I am thus looking forward to
Reid and Lomas-Francis’s electronic version of Blood
Group Antigens & Antibodies in the not-too-distant
future.
Geralyn M. Meny, MD
Medical Director
American Red Cross Biomedical Services
700 Spring Garden Street
Philadelphia, PA 19123
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The basic biology of stem cell activation and
perpetuation is by no means a mature field, still more
mysterious than resolved. However, there is a tendency
toward rapid transfer of method from the bench to the
clinic. Thus,given the rich advances made in both stem
cell transplantation (SCT) and molecular medicine
during the last decade, a textbook devoted to relevant
laboratory methods is a welcome necessity.
This volume, one of an extensive series devoted to
such applications in various medical specialties, begins
with a brief overview of the topics covered and their
clinical relevance. The first chapter devotes itself to
evaluation of stem cells from the standpoint of
quiescence versus activation, and self-renewal versus
differentiation. A means of characterizing the distinct
gene expression signatures of murine stem cells in
different states is outlined, with detailed discussion of
quality control and bioinformatics strategies for analysis.
Chapter 2 describes in vivo imaging methods, which
reveal the fate of labeled, transplanted stem cells in mice
and provide insight into stem cell trafficking. The
eventual development of translational approaches seems
certain,and the clinical utility of suchmethods is obvious.
Chapters 3 through 6 focus on HLA. Chapter 3 gives
a nice overview of available molecular typing methods
and utilization strategies in the context of SCT. Chapter
4 focuses on sequence-specific primed PCR in the
typing of HLA Class I and II,providing a rationale for its
preferential use in unrelated transplantation (compared
with sequence-specific oligonucleotide-primed PCR
[SSO-PCR]) and a comprehensive description of the
steps involved. Chapter 5 complements this with a
similar description of SSO-PCR and its rendering on the
Luminex, one of two available commercial systems.
Chapter 6 discusses yet a third typing method and its
role in the repertoire: sequencing-based typing,with its
unique ability to define HLA type unambiguously at the
allelic level.
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Chapters 7 through 10 examine molecular typing
for non-MHC loci. Chapter 7 discusses the major impact
minor histocompatibility antigens can have on outcome
in HLA-matched SCT, lists available information about
these antigens and primary references, and summarizes
the typing methods. Chapter 8 delves into non-HLA
gene polymorphisms involving immune regulatory
molecules, such as cytokines, steroid receptors, and
response mediators, and their effect on SCT outcome.
The author contrasts the simpler genomic variations
found in such polymorphisms with those involving HLA
and addresses study design and data interpretation
issues as well as relevant methods. The authors of
Chapter 9 report an association between single
nucleotide polymorphisms in the intracytoplasmic
epithelial receptor, NOD2/CARD15, and severe GVHD
and mortality in HLA-identical SCT. They include
discussion of their findings and a detailed methods
section. Chapter 10 reviews the role of natural killer
cells and killer immunoglobulin-like receptors (KIR) in
posttransplant immunologic dynamics, the structure of
the relevant genes, and a fully elaborated PCR strategy
for typing KIR polymorphisms.
Chapter 11 returns to the theme of stem cell
trafficking, now in the context of histologic evaluation
of human tissue, and presents methods for identifying
marrow-derived nonhematopoietic cells by double
labeling with immunohistochemistry and in situ
hybridization. The applications,utility,and limitations of
the approach are also discussed.
Chapters 12 and 13 tackle minimal residual disease
(MRD), a key area of interest for clinicians. In Chapter
12 the author covers relevant chromosomal aberrations
and those methods applicable to autologous and
allogeneic SCT for chronic and acute myeloid disorders.
These methods include real-time PCR (RT-PCR), and
multiplex RT-PCR. Chapter 13 switches to lymphoid
disorders,and the use of qualitative and quantitative PCR
and quantitative RT-PCR in documenting MRD and
monitoring tumor burden.
Chapter 14 shifts to the related area of molecular
surveillance of hematopoietic chimerism. The author
provides a thorough technical and theoretical
description of the use of lineage-specific chimerism
analysis in the detection of impending graft rejection
and relapse. He compares this method favorably from
the standpoint of both sensitivity and specificity with
the common approach of microsatellite analysis by PCR.
In the book’s final chapter, the authors leave genetic
analysis altogether,reporting on the utility of proteomic
screening as a means of assessing patients for
complications after allogeneic SCT. The specific method
described is capillary electrophoresis coupled on-line to
an electrospray-ionization-time-of-flight-mass spectrom-
eter for the analysis of biomarkers in human urine.
In summary,Methods in Molecular Medicine, Bone
Marrow and Stem Cell Transplantation offers detailed
instructions for a range of sophisticated methods and
couches them in brief reviews of both the reported
experience and suggestions for application. It is
recommended as a resource for those involved in SCT as
either clinicians or investigators.
David Moolten, MD
Medical Director
American Red Cross Biomedical Services
700 Spring Garden Street
Philadelphia, PA 19123
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